Prieto J - Search Results

1

Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.

Fernandez-Ruiz V, Kawa M, Berasain C, Iñiguez M, Schmitz V, Martinez-Ansó E, Iñarrairaegui M, Herrero I, Sangro B, D'Avola D, Quiroga J, Qian C, Prieto J. Fernandez-Ruiz V, et al. Among authors: prieto j. J Hepatol. 2011 Oct;55(4):828-37. doi: 10.1016/j.jhep.2011.01.036. Epub 2011 Feb 18. J Hepatol. 2011. PMID: 21334399

2

Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I.

Mirpuri E, García-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA. Mirpuri E, et al. Among authors: prieto j. Int J Biochem Cell Biol. 2002 Mar;34(3):242-52. doi: 10.1016/s1357-2725(01)00123-6. Int J Biochem Cell Biol. 2002. PMID: 11849991 Free article.

3

Gene therapy of hepatocellular carcinoma and gastrointestinal tumors.

Sangro B, Qian C, Schmitz V, Prieto J. Sangro B, et al. Among authors: prieto j. Ann N Y Acad Sci. 2002 Jun;963:6-12. doi: 10.1111/j.1749-6632.2002.tb04089.x. Ann N Y Acad Sci. 2002. PMID: 12095923

4

Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma.

Sangro B, Rios R, Bilbao I, Beloqui O, Herrero JI, Quiroga J, Prieto J. Sangro B, et al. Among authors: prieto j. Oncology. 2002;62(4):293-8. doi: 10.1159/000065059. Oncology. 2002. PMID: 12138235

5

New strategies to enhance gene therapy efficiency.

Qian C, Sangro B, Prieto J. Qian C, et al. Among authors: prieto j. Gastroenterology. 2002 Aug;123(2):639-42. doi: 10.1053/gast.2002.35132. Gastroenterology. 2002. PMID: 12145817 No abstract available.

6

[In vivo evaluation of gene transfer].

Mazzolini G, Sangro B, Prieto J. Mazzolini G, et al. Among authors: prieto j. Medicina (B Aires). 2002;62(4):375-6. Medicina (B Aires). 2002. PMID: 12325500 Spanish. No abstract available.

7

Gene therapy of neoplastic liver diseases.

Sangro B, Herraiz M, Prieto J. Sangro B, et al. Among authors: prieto j. Int J Biochem Cell Biol. 2003 Feb;35(2):135-48. doi: 10.1016/s1357-2725(02)00163-2. Int J Biochem Cell Biol. 2003. PMID: 12479864 Review.

8

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage.

Lasarte JJ, Sarobe P, Boya P, Casares N, Arribillaga L, de Cerio AL, Gorraiz M, Borrás-Cuesta F, Prieto J. Lasarte JJ, et al. Among authors: prieto j. Hepatology. 2003 Feb;37(2):461-70. doi: 10.1053/jhep.2003.50073. Hepatology. 2003. PMID: 12540797 Free article.

9

In vitro and in vivo comparative study of chimeric liver-specific promoters.

Kramer MG, Barajas M, Razquin N, Berraondo P, Rodrigo M, Wu C, Qian C, Fortes P, Prieto J. Kramer MG, et al. Among authors: prieto j. Mol Ther. 2003 Mar;7(3):375-85. doi: 10.1016/s1525-0016(02)00060-6. Mol Ther. 2003. PMID: 12668133 Free article.

10

A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.

Lucena JF, Herrero JI, Quiroga J, Sangro B, Garcia-Foncillas J, Zabalegui N, Sola J, Herraiz M, Medina JF, Prieto J. Lucena JF, et al. Among authors: prieto j. Gastroenterology. 2003 Apr;124(4):1037-42. doi: 10.1053/gast.2003.50144. Gastroenterology. 2003. PMID: 12671900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,073 results

Search Page

Filters